de State Street PTC Therapeutics PTCT Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 375 M | Comprar |
4,598,952
+252,433
| +6% | +USD 18.2 M | 0.01% | 708 |
|
|
2026
Q1 | USD 296 M | Comprar |
4,346,519
+140,393
| +3% | +USD 9.9 M | 0.01% | 760 |
|
|
2025
Q4 | USD 319 M | Comprar |
4,206,126
+1,071,343
| +34% | +USD 77.9 M | 0.01% | 726 |
|
|
2025
Q3 | USD 192 M | Comprar |
3,134,783
+138,329
| +5% | +USD 7.21 M | 0.01% | 959 |
|
|
2025
Q2 | USD 146 M | Comprar |
2,996,454
+541,558
| +22% | +USD 25.7 M | 0.01% | 1095 |
|
|
2025
Q1 | USD 125 M | Vender |
2,454,896
-253,100
| -9% | -USD 12.6 M | 0.01% | 1159 |
|
|
2024
Q4 | USD 122 M | Vender |
2,707,996
-191,044
| -7% | -USD 8.18 M | ﹤0.01% | 1228 |
|
|
2024
Q3 | USD 108 M | Comprar |
2,899,040
+149,700
| +5% | +USD 5.01 M | ﹤0.01% | 1284 |
|
|
2024
Q2 | USD 84.1 M | Vender |
2,749,340
-1,360,452
| -33% | -USD 44.1 M | ﹤0.01% | 1368 |
|
|
2024
Q1 | USD 120 M | Vender |
4,109,792
-524,163
| -11% | -USD 14.7 M | 0.01% | 1193 |
|
|
2023
Q4 | USD 128 M | Comprar |
4,633,955
+1,465,095
| +46% | +USD 33.5 M | 0.01% | 1137 |
|
|
2023
Q3 | USD 71 M | Vender |
3,168,860
-1,624
| -0.1% | -USD 60.4 k | ﹤0.01% | 1405 |
|
|
2023
Q2 | USD 129 M | Comprar |
3,170,484
+265,351
| +9% | +USD 13 M | 0.01% | 1054 |
|
|
2023
Q1 | USD 141 M | Vender |
2,905,133
-533,358
| -16% | -USD 24.4 M | 0.01% | 975 |
|
|
2022
Q4 | USD 131 M | Comprar |
3,438,491
+615,259
| +22% | +USD 25.6 M | 0.01% | 997 |
|
|
2022
Q3 | USD 142 M | Vender |
2,823,232
-801,645
| -22% | -USD 39.3 M | 0.01% | 897 |
|
|
2022
Q2 | USD 145 M | Comprar |
3,624,877
+440,850
| +14% | +USD 15.5 M | 0.01% | 925 |
|
|
2022
Q1 | USD 119 M | Comprar |
3,184,027
+382,596
| +14% | +USD 14.7 M | 0.01% | 1176 |
|
|
2021
Q4 | USD 112 M | Comprar |
2,801,431
+152,810
| +6% | +USD 5.85 M | 0.01% | 1216 |
|
|
2021
Q3 | USD 98.6 M | Comprar |
2,648,621
+271,594
| +11% | +USD 11.2 M | 0.01% | 1273 |
|
|
2021
Q2 | USD 100 M | Comprar |
2,377,027
+345,169
| +17% | +USD 14.8 M | 0.01% | 1285 |
|
|
2021
Q1 | USD 96.2 M | Vender |
2,031,858
-149,739
| -7% | -USD 8.89 M | 0.01% | 1265 |
|
|
2020
Q4 | USD 133 M | Vender |
2,181,597
-102,011
| -4% | -USD 6.01 M | 0.01% | 946 |
|
|
2020
Q3 | USD 107 M | Vender |
2,283,608
-53,175
| -2% | -USD 2.62 M | 0.01% | 930 |
|
|
2020
Q2 | USD 119 M | Vender |
2,336,783
-35,894
| -2% | -USD 1.76 M | 0.01% | 864 |
|
|
2020
Q1 | USD 106 M | Comprar |
2,372,677
+33,731
| +1% | +USD 1.7 M | 0.01% | 827 |
|
|
2019
Q4 | USD 112 M | Comprar |
2,338,946
+264,044
| +13% | +USD 11.2 M | 0.01% | 979 |
|
|
2019
Q3 | USD 70.2 M | Vender |
2,074,902
-238,866
| -10% | -USD 10.4 M | 0.01% | 1215 |
|
|
2019
Q2 | USD 104 M | Vender |
2,313,768
-187,158
| -7% | -USD 7.39 M | 0.01% | 1007 |
|
|
2019
Q1 | USD 94.1 M | Comprar |
2,500,926
+102,612
| +4% | +USD 3.45 M | 0.01% | 1045 |
|
|
2018
Q4 | USD 82.3 M | Comprar |
2,398,314
+122,136
| +5% | +USD 4.39 M | 0.01% | 1021 |
|
|
2018
Q3 | USD 107 M | Vender |
2,276,178
-240,750
| -10% | -USD 10 M | 0.01% | 1029 |
|
|
2018
Q2 | USD 84.9 M | Comprar |
2,516,928
+355,522
| +16% | +USD 11.1 M | 0.01% | 1148 |
|
|
2018
Q1 | USD 58.5 M | Vender |
2,161,406
-562,909
| -21% | -USD 14.3 M | 0.01% | 1325 |
|
|
2017
Q4 | USD 45.4 M | Comprar |
2,724,315
+969,129
| +55% | +USD 16.4 M | ﹤0.01% | 1486 |
|
|
2017
Q3 | USD 35.1 M | Comprar |
1,755,186
+75,571
| +4% | +USD 1.48 M | ﹤0.01% | 1613 |
|
|
2017
Q2 | USD 30.8 M | Vender |
1,679,615
-217,059
| -11% | -USD 2.92 M | ﹤0.01% | 1685 |
|
|
2017
Q1 | USD 18.7 M | Comprar |
1,896,674
+1,302,278
| +219% | +USD 15.8 M | ﹤0.01% | 1995 |
|
|
2016
Q4 | USD 6.48 M | Vender |
594,396
-64,950
| -10% | -USD 681 k | ﹤0.01% | 2543 |
|
|
2016
Q3 | USD 9.24 M | Comprar |
659,346
+76,998
| +13% | +USD 626 k | ﹤0.01% | 2225 |
|
|
2016
Q2 | USD 4.09 M | Vender |
582,348
-68,287
| -10% | -USD 501 k | ﹤0.01% | 2710 |
|
|
2016
Q1 | USD 4.19 M | Vender |
650,635
-871,274
| -57% | -USD 15.1 M | ﹤0.01% | 2645 |
|
|
2015
Q4 | USD 49.3 M | Comprar |
1,521,909
+359,057
| +31% | +USD 10.6 M | 0.01% | 1189 |
|
|
2015
Q3 | USD 31 M | Comprar |
1,162,852
+183,554
| +19% | +USD 7.85 M | ﹤0.01% | 1445 |
|
|
2015
Q2 | USD 47.1 M | Comprar |
979,298
+285,814
| +41% | +USD 16.7 M | 0.01% | 1308 |
|
|
2015
Q1 | USD 42.2 M | Vender |
693,484
-2,413
| -0.3% | -USD 147 k | ﹤0.01% | 1344 |
|
|
2014
Q4 | USD 36 M | Vender |
695,897
-125,917
| -15% | -USD 5.54 M | ﹤0.01% | 1396 |
|
|
2014
Q3 | USD 36.2 M | Vender |
821,814
-24,024
| -3% | -USD 752 k | ﹤0.01% | 1348 |
|
|
2014
Q2 | USD 22.1 M | Comprar |
845,838
+152,382
| +22% | +USD 3.26 M | ﹤0.01% | 1748 |
|
|
2014
Q1 | USD 18.1 M | Comprar |
693,456
+582,142
| +523% | +USD 15.6 M | ﹤0.01% | 1858 |
|
|
2013
Q4 | USD 1.89 M | Comprar |
111,314
+24,187
| +28% | +USD 425 k | ﹤0.01% | 3093 |
|
|
2013
Q3 | USD 1.87 M | Comprar |
+87,127
| Nuevas | +USD 1.51 M | ﹤0.01% | 3075 |
|
Otros fondos que tienen PTCT en su cartera
Posición de State Street en PTCT: resumen de T2 2026
State Street aumentó su participación en PTC Therapeutics (PTCT) en 5.8% durante T2 2026, al comprar aproximadamente USD 18.2 M y elevar la posición a 4,598,952 acciones con un valor de USD 375 M. La posición representa 0.01% de la cartera y ocupa el puesto #708.
State Street reportó por primera vez una posición en PTCT en T3 2013 y la ha mantenido durante 52 trimestres desde entonces. Al cierre de T2 2026, 382 fondos que sigue Wall St. Rank mantienen una posición en PTCT.
- Al cierre de T2 2026, State Street tenía 4,598,952 acciones de PTC Therapeutics con un valor de USD 375 M.
- State Street compró 252,433 acciones de PTC Therapeutics en T2 2026, por un monto estimado de USD 18.2 M.
- PTC Therapeutics representó 0.01% de la cartera de State Street en T2 2026 y fue su posición número 708.
- State Street reportó por primera vez una posición en PTC Therapeutics en T3 2013 y la ha mantenido durante 52 trimestres desde entonces.
- Al cierre de T2 2026, 382 fondos que sigue Wall St. Rank tenían PTC Therapeutics en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.